Crossmark

Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in routine care

Crossref DOI link: https://doi.org/10.1186/s13075-019-1893-z

Published Online: 2019-05-07

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Burgers, L. E. https://orcid.org/0000-0003-1885-2693
van der Pol, J. A.

Huizinga, T. W. J.

Allaart, C. F.

van der Helm-van Mil, A. H. M.
Funding

Funding for this research was provided by:

European Research Council (714312)

NWO (Vidi)
License Information

Text and Data Mining valid from 2019-05-07
More Information

Article History

Received: 19 November 2018

Accepted: 4 April 2019

First Online: 7 May 2019

Ethics approval and consent to participate

: The study protocol of the IMPROVED study and the EAC cohort were approved by the local medical ethical committee of the Leiden University Medical Center. All patients provided written informed consent.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below